Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3, 2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases
The metabolic activation of several carcinogenic N-hydroxy (N-OH)-arylamines by cytosolic S-acetyl coenzyme A (AcCoA)-dependent enzymes was examined in tissues and species susceptible to arylamine carcinogenesis. Comparisons of the AcCoA-dependent activity were also made with known cytosolic arylhyd...
Gespeichert in:
Veröffentlicht in: | Carcinogenesis (New York) 1986-06, Vol.7 (6), p.919-926 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The metabolic activation of several carcinogenic N-hydroxy (N-OH)-arylamines by cytosolic S-acetyl coenzyme A (AcCoA)-dependent enzymes was examined in tissues and species susceptible to arylamine carcinogenesis. Comparisons of the AcCoA-dependent activity were also made with known cytosolic arylhydroxamic acid-dependent acyltransferases and with the ability of different acyl donors to mediate the binding of N-OH-arylamines to DNA. With rat hepatic cytosol, AcCoA-dependent DNA binding was demonstrated for several [3H]N-OH-arylamines, in the order: N-OH-3, 2'-dimethyl-4-aminobiphenyl (N-OH-DMABF), N-OH-2-aminofluorene (N-OH-AF) > N-OH-4-aminobiphenyl > N-OH-N'-acetylbenzidine > N-OH-2-naphthylamine; N-OH-N-methyl-4-amino-azobenzene was not a substrate. No activity was detected in dog hepatic or bladder cytosol with any of the N-OH-arylamines tested. Using either N-OH-DMABP or N-OH-AF and rat hepatic cytosol, activation to DNA-bound products was also detected with acetoacetyl- and propionyl-CoA but not with folinic acid or six other acyl CoA's. However, p-nitro-phenyl acetate which is known to generate acetyl-enzyme intermediates effectively replaced AcCoA. Subcellular fractionation of rat liver showed that the AcCoA-dependent DNA-binding of N-OH-DMABP with cytosol was 5 times greater than that obtained with the microsomal or mitochondrial/nuclear fractions. Furthermore, the cytosolic activity was insensitive to inhibition by the esterase/deacetylase inhibitor, paraoxon; while the activity of the other subcellular fractions was completely inhibited (>95%). AcCoA-dependent activation of N-OH-DMABP was also detected with rat tissue cytosols from intestine, mammary gland and kidney, which like the liver, are targets for arylamine-induced tumorigenesis. Using N-OH-DMABP, AcCoA-dependent DNA-binding activity was also detected in the hepatic cytosols from several species in the order: rabbit > hamster > rat, human > guinea pig > mouse. In contrast, the arylhydroxamic acid, N-OH-N-acetyl-DMABP, was not activated to a DNA-binding metabolite by the hepatic cytosolic N, O-acyltransferase of any of these species, thus suggesting that the AcCoA-mediated binding of N-OH-DMABP results from the direct formation of N-acetoxy-DMABP. With N-OH-AF as the substrate, the AcCoA-dependent activation was in the order: rabbit > guinea pig, hamster > mouse > human, rat. In contrast to the AcCoA-dependent activation of N-OH-AF, only very low N-OH-N-acetyl-4-aminobiphenyl-dependent tra |
---|---|
ISSN: | 0143-3334 1460-2180 |
DOI: | 10.1093/carcin/7.6.919 |